Cargando…

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomica...

Descripción completa

Detalles Bibliográficos
Autores principales: Blot, Stijn, Antonelli, Massimo, Arvaniti, Kostoula, Blot, Koen, Creagh-Brown, Ben, de Lange, Dylan, De Waele, Jan, Deschepper, Mieke, Dikmen, Yalim, Dimopoulos, George, Eckmann, Christian, Francois, Guy, Girardis, Massimo, Koulenti, Despoina, Labeau, Sonia, Lipman, Jeffrey, Lipovestky, Fernando, Maseda, Emilio, Montravers, Philippe, Mikstacki, Adam, Paiva, José-Artur, Pereyra, Cecilia, Rello, Jordi, Timsit, Jean-Francois, Vogelaers, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863788/
https://www.ncbi.nlm.nih.gov/pubmed/31664501
http://dx.doi.org/10.1007/s00134-019-05819-3
_version_ 1783471761942118400
author Blot, Stijn
Antonelli, Massimo
Arvaniti, Kostoula
Blot, Koen
Creagh-Brown, Ben
de Lange, Dylan
De Waele, Jan
Deschepper, Mieke
Dikmen, Yalim
Dimopoulos, George
Eckmann, Christian
Francois, Guy
Girardis, Massimo
Koulenti, Despoina
Labeau, Sonia
Lipman, Jeffrey
Lipovestky, Fernando
Maseda, Emilio
Montravers, Philippe
Mikstacki, Adam
Paiva, José-Artur
Pereyra, Cecilia
Rello, Jordi
Timsit, Jean-Francois
Vogelaers, Dirk
author_facet Blot, Stijn
Antonelli, Massimo
Arvaniti, Kostoula
Blot, Koen
Creagh-Brown, Ben
de Lange, Dylan
De Waele, Jan
Deschepper, Mieke
Dikmen, Yalim
Dimopoulos, George
Eckmann, Christian
Francois, Guy
Girardis, Massimo
Koulenti, Despoina
Labeau, Sonia
Lipman, Jeffrey
Lipovestky, Fernando
Maseda, Emilio
Montravers, Philippe
Mikstacki, Adam
Paiva, José-Artur
Pereyra, Cecilia
Rello, Jordi
Timsit, Jean-Francois
Vogelaers, Dirk
author_sort Blot, Stijn
collection PubMed
description PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). METHODS: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. RESULTS: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. CONCLUSION: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-019-05819-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6863788
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-68637882019-12-05 Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project Blot, Stijn Antonelli, Massimo Arvaniti, Kostoula Blot, Koen Creagh-Brown, Ben de Lange, Dylan De Waele, Jan Deschepper, Mieke Dikmen, Yalim Dimopoulos, George Eckmann, Christian Francois, Guy Girardis, Massimo Koulenti, Despoina Labeau, Sonia Lipman, Jeffrey Lipovestky, Fernando Maseda, Emilio Montravers, Philippe Mikstacki, Adam Paiva, José-Artur Pereyra, Cecilia Rello, Jordi Timsit, Jean-Francois Vogelaers, Dirk Intensive Care Med Original PURPOSE: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). METHODS: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. RESULTS: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. CONCLUSION: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-019-05819-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-10-29 2019 /pmc/articles/PMC6863788/ /pubmed/31664501 http://dx.doi.org/10.1007/s00134-019-05819-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original
Blot, Stijn
Antonelli, Massimo
Arvaniti, Kostoula
Blot, Koen
Creagh-Brown, Ben
de Lange, Dylan
De Waele, Jan
Deschepper, Mieke
Dikmen, Yalim
Dimopoulos, George
Eckmann, Christian
Francois, Guy
Girardis, Massimo
Koulenti, Despoina
Labeau, Sonia
Lipman, Jeffrey
Lipovestky, Fernando
Maseda, Emilio
Montravers, Philippe
Mikstacki, Adam
Paiva, José-Artur
Pereyra, Cecilia
Rello, Jordi
Timsit, Jean-Francois
Vogelaers, Dirk
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title_full Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title_fullStr Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title_full_unstemmed Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title_short Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
title_sort epidemiology of intra-abdominal infection and sepsis in critically ill patients: “abses”, a multinational observational cohort study and esicm trials group project
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863788/
https://www.ncbi.nlm.nih.gov/pubmed/31664501
http://dx.doi.org/10.1007/s00134-019-05819-3
work_keys_str_mv AT blotstijn epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT antonellimassimo epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT arvanitikostoula epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT blotkoen epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT creaghbrownben epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT delangedylan epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT dewaelejan epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT descheppermieke epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT dikmenyalim epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT dimopoulosgeorge epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT eckmannchristian epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT francoisguy epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT girardismassimo epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT koulentidespoina epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT labeausonia epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT lipmanjeffrey epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT lipovestkyfernando epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT masedaemilio epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT montraversphilippe epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT mikstackiadam epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT paivajoseartur epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT pereyracecilia epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT rellojordi epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT timsitjeanfrancois epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT vogelaersdirk epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject
AT epidemiologyofintraabdominalinfectionandsepsisincriticallyillpatientsabsesamultinationalobservationalcohortstudyandesicmtrialsgroupproject